We are live on ! Find out more
KCM

Kingdon Capital Management Portfolio holdings

AUM $911M
1-Year Est. Return 51.11%
This Fund
S&P 500
This Quarter Est. Return
+10.84%
1 Year Est. Return
+51.11%
3 Year Est. Return
+185.44%
5 Year Est. Return
+284.29%
10 Year Est. Return
+2,022.7%
AUM
$502M
AUM Growth
-$280M
Cap. Flow
-$286M
Cap. Flow %
-56.87%
Top 10 Hldgs %
41.94%
Holding
82
New
22
Increased
7
Reduced
5
Closed
32

Top Sells

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$25.9M
2
ELV icon
Elevance Health
ELV
+$18.6M
3
LNG icon
Cheniere Energy
LNG
+$15.1M
4
CCK icon
Crown Holdings
CCK
+$13.9M
5
AMZN icon
Amazon
AMZN
+$13.6M

Sector Composition

Rank Sector Weight
1 Industrials 26.62%
2 Healthcare 19.8%
3 Technology 11.8%
4 Financials 9.18%
5 Utilities 2.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BN icon
26
Brookfield
BN
$108B
$9.44M 1.88%
+450,000
New +$10.1M
WFC icon
27
CALL
Wells Fargo
WFC
$264B
$8.26M 1.64%
+200,000
New +$8.85M
VNQ icon
28
PUT
Vanguard Real Estate ETF
VNQ
$39B
$8.25M 1.64%
+100,000
New +$8.29M
BX icon
29
PUT
Blackstone
BX
$110B
$7.42M 1.48%
+100,000
New +$8.64M
PLAY icon
30
Dave & Buster's
PLAY
$357M
$7.09M 1.41%
+200,000
New +$7.23M
PRAX icon
31
Praxis Precision Medicines
PRAX
$10.1B
$6.8M 1.35%
190,399
+113,333
+147% +$3.53M
KRE icon
32
PUT
State Street SPDR S&P Regional Banking ETF
KRE
$4.64B
$5.87M 1.17%
100,000
-400,000
-80% -$24.6M
OPTN
33
DELISTED
OptiNose
OPTN
$5.83M 1.16%
209,949
+56,667
+37% +$2.15M
XAIR icon
34
Beyond Air
XAIR
$3.86M
$5.17M 1.03%
1,990
WNS
35
DELISTED
WNS Holdings
WNS
$5M 1%
62,500
+25,000
+67% +$2.06M
LEN icon
36
PUT
Lennar Class A
LEN
$21.2B
$4.53M 0.9%
+51,650
New +$4.18M
DHI icon
37
PUT
D.R. Horton
DHI
$42.3B
$4.46M 0.89%
+50,000
New +$4.01M
SLGL icon
38
Sol-Gel Technologies
SLGL
$288M
$3.8M 0.76%
83,280
TPIC
39
DELISTED
TPI Composites
TPIC
$3.04M 0.61%
300,000
-50,000
-14% -$521K
MSAC
40
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
$3.02M 0.6%
300,000
GEG icon
41
Great Elm Group
GEG
$69.3M
$2.79M 0.55%
1,379,049
SCYX icon
42
SCYNEXIS
SCYX
$52M
$2.02M 0.4%
162,131
BBBY
43
CALL
Bed Bath & Beyond
BBBY
$442M
$1.94M 0.39%
+110,000
New +$2.36M
BBBY
44
Bed Bath & Beyond
BBBY
$442M
$1.94M 0.39%
110,000
CRIS icon
45
Curis
CRIS
$7.83M
$1.39M 0.28%
6,311
NVNO
46
enVVeno Medical
NVNO
$7.09M
$1.12M 0.22%
6,262
VINC
47
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$393K 0.08%
19,250
JSPR icon
48
Jasper Therapeutics
JSPR
$23.6M
$261K 0.05%
54,000
EUCRW
49
DELISTED
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
$3.54K ﹤0.01%
66,665
MSACW
50
DELISTED
Medicus Sciences Acquisition Corp. Warrant
MSACW
$3.12K ﹤0.01%
33,332

Similar funds

Kingdon Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Kingdon Capital Management held 82 positions worth $502M, down 36% from $782M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Kingdon Capital Management withdrew a net $286M in Q4 2022, closing 32 positions and reducing 5 holdings. Its most notable exit was Baxter International, an estimated $25.9M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 27% of assets, up from 9% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Kingdon Capital Management opened a new position in Boeing worth $25.5M.

  • Kingdon Capital Management's largest Q4 2022 buy was Boeing: 133,700 shares worth $25.5M.
  • Kingdon Capital Management added most to Ferguson in Q4 2022, an estimated $8.34M increase.
  • Kingdon Capital Management's biggest Q4 2022 reduction was Aramark, cutting an estimated $5.73M.
  • Kingdon Capital Management fully exited Baxter International in Q4 2022, selling an estimated $25.9M.
  • Kingdon Capital Management's ten largest holdings make up 42% of its $502M portfolio in Q4 2022.
  • Kingdon Capital Management opened 22 new positions and closed 32 in Q4 2022.
  • Kingdon Capital Management's portfolio value fell 36% quarter-over-quarter to $502M.

Based on Kingdon Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.